Previous Article | Next Article ![]()
Journal of Virology, November 2009, p. 11959-11965, Vol. 83, No. 22
0022-538X/09/$08.00+0 doi:10.1128/JVI.00689-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
2V
2 T Cells in Smallpox Vaccination and Monkeypox Virus Infection
Dan Huang,1,
Huiyong Wei,1
Richard C. Wang,1
Crystal Y. Chen,1
Ling Shen,2
Wenhong Zhang,3
Jialin Jin,1 and
Zheng W. Chen1*
Department of Microbiology and Immunology, Center for Primate Biomedical Research, University of Illinois College of Medicine at Chicago, Chicago, Illinois,1 Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts,2 Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China3
Received 2 April 2009/ Accepted 26 August 2009
Little is known about the in vivo kinetics of T-cell responses in smallpox/monkeypox. We showed that macaque V
2V
2 T cells underwent 3-week-long expansion after smallpox vaccine immunization and displayed simple reexpansion in association with sterile anti-monkeypox virus (anti-MPV) immunity after MPV challenge. Virus-activated V
2V
2 T cells exhibited gamma interferon-producing effector function after phosphoantigen stimulation. Surprisingly, like
β T cells, suboptimally primed V
2V
2 T cells in vaccinia virus/cidofovir-covaccinated macaques mounted major recall-like expansion after MPV challenge. Finally, V
2V
2 T cells localized in inflamed lung tissues for potential regulation. Our studies provide the first in vivo evidence that viruses, despite their inability to produce exogenous phosphoantigen, can induce expansion, reexpansion, and recall-like expansion of V
2V
2 T cells and stimulate their antimicrobial cytokine response.
Published ahead of print on 9 September 2009.
L.S. and D.H. contributed equally to the work.
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»